ReviewFrontiers in immunology2026
Muscle-lung crosstalk in COPD: how exercise training modulates protein metabolism and inflammation in experimental COPD models.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic obstructive pulmonary disease (COPD) is a multisystem inflammatory disease in which skeletal muscle dysfunction contributes substantially to exercise intolerance, reduced functional capacity, and poor clinical outcomes. Increasing evidence suggests that bidirectional communication between skeletal muscle and the lung plays an important role in disease progression and in mediating the beneficial effects of exercise training. This review summarizes current knowledge of muscle-lung crosstalk in cigarette smoke (CS)-induced experimental models of COPD, while incorporating complementary evidence from other experimental models where relevant to support mechanistic interpretation. We discuss the molecular pathways linking pulmonary inflammation to skeletal muscle dysfunction, including systemic inflammation, oxidative stress, mitochondrial dysfunction, impaired protein turnover, and metabolic dysregulation. We further examine how skeletal muscle may influence pulmonary biology through the release of myokines, metabolites, extracellular vesicles, and mitochondrial-derived signaling molecules, highlighting their potential roles in inter-organ communication. Particular emphasis is placed on the capacity of exercise training to modulate these pathways by improving muscle proteostasis, mitochondrial function, systemic inflammatory status, and pulmonary outcomes in experimental model of COPD. We also discuss important considerations for interpreting findings across experimental models, including differences in cigarette smoke exposure paradigms, exercise timing, and distinctions between locomotor and respiratory muscles. Finally, we identify key gaps in current knowledge and outline future experimental strategies needed to define the molecular mechanisms underlying muscle-lung crosstalk and to facilitate translation of these findings into exercise-based therapeutic approaches for COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.